✦ LIBER ✦

Managing change in biotech: mergers and acquisitions

✍ Scribed by Rafferty, Mary Ann

Book ID: 109903843
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 528 KB
Volume: 25
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0607-689

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mergers and acquisitions in the pharmace

Mergers and acquisitions in the pharmaceutical and biotech industries

✍ Patricia M. Danzon; Andrew Epstein; Sean Nicholson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

## Abstract We examine the determinants and effects of M&A activity in the pharmaceutical/biotechnology industry using SDC data on 383 firms from 1988 to 2001. For large firms, mergers are a response to expected excess capacity due to patent expirations and gaps in a firm's product pipeline. For sm

Managing change in biotech: startup and

Managing change in biotech: startup and growth

✍ Rafferty, Mary Ann 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Managing change in biotech: setbacks and

Managing change in biotech: setbacks and failures

✍ Rafferty, Mary Ann 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Mergers and acquisitions: some implicati

Mergers and acquisitions: some implications of cultural change

✍ S. J. CAVANAGH 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Mergers and acquisitions: Increasing the

Mergers and acquisitions: Increasing the speed of change

✍ Mercer Bing, Catherine; Wingrove, Clinton 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The DySIIM model for managing IS integra

The DySIIM model for managing IS integration in mergers and acquisitions

✍ Stefan Henningsson; Sven Carlsson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB